Decisions about Limiting Treatment in Cancer Patients: A Systematic Review and Clinical Ethical Analysis of Reported Variables

Journal of Palliative Medicine

Volumn 18, Issue 10, 2015, Pages 884-892

  Schildmann, Jan ^a   Baumann, Anne ^b   Cakar, Mahmut ^a   Salloch, Sabine ^a   Vollmann, Jochen ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CANCER THERAPY; CLINICAL DECISION MAKING; DEMOGRAPHY; ETHNICITY; FAMILY ATTITUDE; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL ETHICS; MENTAL HEALTH; PATIENT PREFERENCE; PROFESSIONALISM; REVIEW; SOCIAL STATUS; SYSTEMATIC REVIEW; TERMINAL CARE; TREATMENT WITHDRAWAL; ATTITUDE TO DEATH; BIBLIOGRAPHIC DATABASE; DECISION MAKING; ETHICS; ETHNOLOGY; HUMAN RELATION; NEOPLASMS;

ATTITUDE TO DEATH; DATABASES, BIBLIOGRAPHIC; DECISION MAKING; ETHICAL ANALYSIS; HUMANS; NEOPLASMS; PATIENT PREFERENCE; PROFESSIONAL-FAMILY RELATIONS; TERMINAL CARE; WITHHOLDING TREATMENT;

EID: 84941366268     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2014.0441     Document Type: Review

References (38)

1. Emanuel EJ, Young-Xu Y, Levinsky NG: Chemotherapy use among Medicare beneficiaries at the end of life. Ann Intern Med 2003;38:639-643.
2. Kwok AC, Semel ME, Lipsitz SR: The intensity and variation of surgical care at the end of life: A retrospective cohort study. Lancet 2011;378:1408-1413.
3. Kelley AS: Treatment intensity at end of life: Time to act on the evidence. Lancet 2011;378:1364-1365.
4. Kao S, Shafiq J, Vardy J: Use of chemotherapy at end of life in oncology patients. Ann Oncol 2009;20:1555-1559.
5. Greer JA, Pirl WF, Jackson VA, et al. : Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol 2012;30:394-400.
6. Earle CC, Landrum MB, Souza JM, et al. : Aggressiveness of cancer care near the end of life: Is it a quality-of care issue? J Clin Oncol 2008;26:3860-3866.
7. Earle CC, Neville BA, Landrum MB, et al. : Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 2004;22:315-321.
8. Temel JS, Greer JA, Muzikansky A, et al. : Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010;363:733-742.
9. Smith TJ, Temin S, Alesi ER, et al. : ASCO provisional clinical opinion: The integration of palliative care into standard oncology care. J Clin Oncol 2012;30:880-887.
10. Brock DW: The ideal of shared decision making between physicians and patients. Kennedy Inst Ethics J 1991;1:28-47.
11. Brody B: Life and Death Decision Making. Oxford: Oxford University Press, 1988.
12. Winkler E, Hiddemann W, Marckmann G: Ethical assessment of life-prolonging treatment. Lancet Oncol 2011;12: 720-722.
13. Schneiderman LJ: Defining medical futility and improving medical care. J Bioeth 2011;8:123-131.
14. Buiting HM, Rurup ML, Wijsbek H, et al. : Understanding the provision of chemotherapy to patients with end stage cancer: Qualitative interview study. BMJ 2011;342:1-9.
15. Schildmann J, Tan J, Salloch S, Vollmann J: ''Well, I think there is great variation. . . :'' A qualitative study of oncologists' experiences and views regarding medical criteria and other factors relevant to treatment decisions in advanced cancer. Oncologist 2013;18:90-96.
16. Mack JW, Cronin A, Keating NL, et al. : Associations between end-of-life discussion characteristics and care received near death: A prospective cohort study. J Clin Oncol 2012;30:4387-4395.
17. Winkler EC, Reiter-Theil S, Lange-Riess D: Patient involvement in decisions to limit treatment: The crucial role of agreement between physician and patient. J Clin Oncol 2009;27:2225-2230.
18. Moher D, Liberati A, Tetzlaff J: Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009;6:e1000097.
19. Stroup DF, Berlin JA, Morton SC: Meta-analysis of observational studies in epidemiology: A proposal for reporting. Metaanalysis of observational studies in epidemiology (MOOSE) group. JAMA 2000;283:2008-2012.
20. Scottish Intercollegiate Guidelines Network: Methodology Checklist 3: Cohort Studies. www. sign. Ac. uk/methodology/ checklists. html. Scottish Intercollegiate Guidelines Network. 2014. (Last accessed December 18, 2014. )
21. Hanson LC, Danis M, Mutran E, Keenan NL: Impact of patient incompetence on decisions to use or withhold lifesustaining treatment. Am J Med 1994;97:235-241.
22. Brown NK, Thompson DJ, Prentice RL: Nontreatment and aggressive narcotic therapy among hospitalized pancreatic cancer patients. JAGS 1998;46:839-849.
23. Cesta MA, Cardenas-Turanzas M, Wakefield C, et al. : Lifesupportive therapy withdrawal and length of stay in a large oncologic intensive care unit at the end of life. J Palliat Med 2009;12:713-718.
24. Hui D, Con A, Christie G, Hawley PH: Goals of care and end-of-life decision making for hospitalized patients at a Canadian tertiary care cancer center. J Pain Symptom Manage 2009;38:871-881.
25. Mack JW, Paulk ME, Viswanath K, Prigerson HG: Racial disparities in the outcomes of communication on medical care received near death. Arch Intern Med 2010;170:1533-1540.
26. Morita T, Tsunoda J, Inoue S, Chihara S: Perceptions and decision-making on rehydration of terminally ill cancer patients and family members. AmJHosp PalliatCare 1999;16:509-516.
27. Van der Heide A, Veerbeek L, Swart S, et al. : End-of-life decision making for cancer patients in different clinical settings and the impact of the LCP. J Pain Symptom Manage 2010;39:33-43.
28. Frost DW, Cook DJ, Heyland DK, Fowler RA: Patient and healthcare professional factors influencing end-of-life decision-making during critical illness: A systematic review. Crit Care Med 2011;39:1174-1189.
29. Schildmann J, Molewijk B, Forde R, et al. : Evaluation of clinical ethics support services and its normativity. J Med Ethics 2013;39:681-685.
30. Mitchell SL, Teno JM, Roy J, et al. : Clinical and organizational factors associated with feeding tube use among nursing home residents with advanced cognitive impairment. JAMA 2003;290:73-80.
31. Goodlin SJ, Zhong Z, Lynn J: Factors associated with use of cardiopulmonary resuscitation in seriously ill hospitalized adults. JAMA 1999;282:2333-2339.
32. Kwak J, Haley WE: Current research findings on end-oflife decision making among racially or ethnically diverse groups. Gerontologist 2005;45:634-641.
33. Burt RA: The end of autonomy. Hastings Cent Rep 2005; 35;9-13.
34. Seale C: The role of doctors' religious faith and ethnicity in taking ethically controversial decisions during end-of-life care. J Med Ethics 2010;36:677-682.
35. Salloch S, Ritter P, Wäscher S, et al. : Medical expertise and patient's involvement: A multiperspective qualitative observation study on the patient's role in oncological decision-making. Oncologist 2014;19:654-660.
36. Bosshard G, Nilstun T, Bilsen J: European End-of-Life Consortium: Forgoing treatment at the end of life in 6 European countries. Arch Intern Med 2005;165:401-407.
37. Groenewoud JH, van der Heide A, Kester JG: A nationwide study of decisions to forego life-prolonging treatment in Dutch medical practice. Arch InternMed 2000;160:357-363.
38. Schildmann J, Hoetzel J, Baumann A, et al. : Limitation of treatment at the end of life: An empirical-ethical analysis regarding the practices of physician members of the German Society for Palliative Medicine. J Med Ethics 2011;37: 327-332.